Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease

Citation
Js. Currier et al., Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease, CLIN INF D, 32(11), 2001, pp. 1615-1622
Citations number
34
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
32
Issue
11
Year of publication
2001
Pages
1615 - 1622
Database
ISI
SICI code
1058-4838(20010601)32:11<1615:IOPFMA>2.0.ZU;2-M
Abstract
The epidemiology and natural history of bacterial infections among ambulato ry patients with advanced human immunodeficiency virus (HIV) disease has no t been well described. In this prospective study, 394 subjects were enrolle d and followed at 8-week intervals for a median of 21 months. During follow -up, 164 (42%) of 394 patients developed at least 1 bacterial infection. Th e most common infections were sinusitis, bacterial pneumonia, skin and soft tissue infection, and bronchitis. Serious bacterial infections (defined as bacterial pneumonia, bacteremia, or deep visceral abscess) were reported b y 56 subjects (14%). Female sex, age of <40 years, and Karnofsky score of < less than or equal to>80 were independent risk factors for bacterial infect ions. Prophylaxis with clarithromycin, trimethoprim and sulfamethoxazole, o r both had significant protective effect. The occurrence of any confirmed b acterial infection was associated with a significantly increased risk of mo rtality. This study documents that bacterial infections are common among pa tients with advanced HIV disease, especially among women.